ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619674 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619674; 2) Community: the network communities that were significantly associated with the response to NSC 619674; 3) Molecule: the relationships between components within communities and NSC 619674; 4) MDR: the compounds that were significantly associated with the NSC 619674.

NSC Compound Enrichment Correlation
NSC 709518 Null 0.0147237897640499 0.41318482
NSC 716122 Null 0.0147237897640499 0.17768782
NSC 726365 Null 0.0147237897640499 0.47206657
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0147237897640499 0.22433124
NSC 732737 Null 0.0147237897640499 0.41954448
NSC 746930 Null 0.0147237897640499 0.21338968
NSC 748643 Mitaplatin 0.0147237897640499 0.21560786
NSC 668323 Null 0.0181211508101517 0.23923951
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.0181211508101519 0.2117963
NSC 250682 Oridonin 0.0181211508101519 0.41753131
Total:91  Current:40    [First] [Prev] [Next] [Last]